DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 888 filers reported holding DANAHER CORPORATION in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $31,520,121 | +3.4% | 124,752 | +2.3% | 1.58% | +4.3% |
| Q1 2024 | $30,472,531 | +7.1% | 121,895 | -0.8% | 1.52% | +0.2% |
| Q4 2023 | $28,452,303 | +56.8% | 122,861 | +68.0% | 1.51% | +38.0% |
| Q3 2023 | $18,142,355 | +1.9% | 73,128 | -1.4% | 1.10% | +7.5% |
| Q2 2023 | $17,805,840 | -5.0% | 74,191 | -0.2% | 1.02% | -13.0% |
| Q1 2023 | $18,735,141 | -10.1% | 74,334 | -5.3% | 1.17% | -16.0% |
| Q4 2022 | $20,837,063 | +5.9% | 78,506 | +3.1% | 1.40% | -4.6% |
| Q3 2022 | $19,674,466 | +0.3% | 76,172 | -1.5% | 1.46% | +4.6% |
| Q2 2022 | $19,610,026 | -13.4% | 77,351 | +0.2% | 1.40% | +3.6% |
| Q1 2022 | $22,635,396 | -7.4% | 77,167 | +3.9% | 1.35% | -11.1% |
| Q4 2021 | $24,437,876 | +12.3% | 74,277 | +4.0% | 1.52% | -0.3% |
| Q3 2021 | $21,752,847 | -7.1% | 71,452 | -18.1% | 1.52% | -12.3% |
| Q2 2021 | $23,426,755 | +19.0% | 87,296 | -0.2% | 1.74% | +6.7% |
| Q1 2021 | $19,679,420 | +15.1% | 87,433 | +13.6% | 1.63% | +10.2% |
| Q4 2020 | $17,102,781 | +3.8% | 76,991 | +0.6% | 1.48% | -8.8% |
| Q3 2020 | $16,477,698 | +24.6% | 76,523 | +2.3% | 1.62% | +11.4% |
| Q2 2020 | $13,229,536 | +27.8% | 74,815 | +0.1% | 1.45% | +11.4% |
| Q1 2020 | $10,348,500 | -12.2% | 74,767 | -2.7% | 1.30% | +4.3% |
| Q4 2019 | $11,790,641 | +7.6% | 76,822 | +1.2% | 1.25% | +0.2% |
| Q3 2019 | $10,962,237 | -24.1% | 75,900 | -24.9% | 1.25% | -23.6% |
| Q2 2019 | $14,443,209 | +10.4% | 101,058 | +2.0% | 1.63% | +5.6% |
| Q1 2019 | $13,079,882 | +23.0% | 99,075 | -3.9% | 1.55% | +8.6% |
| Q4 2018 | $10,636,106 | -5.7% | 103,143 | -0.7% | 1.42% | +8.3% |
| Q3 2018 | $11,281,625 | +11.2% | 103,825 | +1.0% | 1.32% | +2.5% |
| Q2 2018 | $10,141,541 | +1.0% | 102,772 | +0.2% | 1.28% | -3.4% |
| Q1 2018 | $10,043,804 | +5.3% | 102,582 | -0.2% | 1.33% | +8.9% |
| Q4 2017 | $9,536,512 | +9.3% | 102,742 | +1.0% | 1.22% | +4.8% |
| Q3 2017 | $8,722,882 | +3.7% | 101,689 | +2.0% | 1.16% | -1.9% |
| Q2 2017 | $8,410,561 | +2.1% | 99,663 | +3.5% | 1.19% | -0.4% |
| Q1 2017 | $8,233,888 | +14.7% | 96,269 | +4.4% | 1.19% | +10.1% |
| Q4 2016 | $7,178,638 | -0.1% | 92,223 | +0.6% | 1.08% | -3.1% |
| Q3 2016 | $7,188,441 | +1776.4% | 91,701 | +2317.6% | 1.12% | +1646.9% |
| Q2 2016 | $383,093 | -95.1% | 3,793 | -95.4% | 0.06% | -94.9% |
| Q1 2016 | $7,777,002 | -4.4% | 81,984 | -6.4% | 1.26% | -8.8% |
| Q4 2015 | $8,135,638 | +1.7% | 87,593 | -6.7% | 1.38% | -0.3% |
| Q3 2015 | $8,003,008 | -1.1% | 93,921 | -0.7% | 1.39% | +11.0% |
| Q2 2015 | $8,095,873 | +0.7% | 94,589 | -0.1% | 1.25% | +0.9% |
| Q1 2015 | $8,038,332 | +12.1% | 94,680 | +0.3% | 1.24% | +11.6% |
| Q4 2014 | $7,171,752 | 0.0% | 94,390 | 0.0% | 1.11% | +2.2% |
| Q3 2014 | $7,171,752 | +42.7% | 94,390 | +47.9% | 1.08% | +50.7% |
| Q2 2014 | $5,024,549 | +74.8% | 63,820 | +66.5% | 0.72% | +59.3% |
| Q1 2014 | $2,874,000 | +21.5% | 38,320 | +25.1% | 0.45% | +20.5% |
| Q4 2013 | $2,364,945 | +18.3% | 30,634 | +6.2% | 0.38% | +10.9% |
| Q3 2013 | $1,998,704 | +38.2% | 28,833 | +26.2% | 0.34% | +25.7% |
| Q2 2013 | $1,446,405 | +29.6% | 22,850 | +27.2% | 0.27% | +31.2% |
| Q1 2013 | $1,116,214 | – | 17,960 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |